US sends Ebola drug to DRC for outbreak trials
The US has provided doses of an experimental antibody drug from Mapp Biopharmaceutical for use in clinical trials to fight the widening Ebola outbreak in the Democratic Republic of the Congo, a health department spokesperson says.
Black News 
The US has provided doses of an experimental antibody drug from Mapp Biopharmaceutical for use in clinical trials to fight the widening Ebola outbreak in the Democratic Republic of the Congo, a health department spokesperson says.
